Cardiovascular disease: identifying and supporting people most at risk of dying early
KEYWORDS: health, evidence, services, disadvantaged, people, interventions, smoking, studies, study, risk, cessation, local, review, effectiveness, smoking cessation

or ineffective, or whether it is equivocal • where there is an effect, the typical size of effect. PHIAC developed draft recommendations through informal consensus, based on the following criteria. • Strength (quality and quantity) of evidence of effectiveness and its applicability to the populations/settings referred to in the scope. • Effect size and potential impact on population health and/or reducing inequalities in health. • Cost effectiveness (for the NHS and other public sector organisations). • Balance of risks and benefits. • Ease of implementation and the anticipated extent of change in practice that would be required. Where possible, recommendations were linked to an evidence statement(s) (see appendix C for details). Where a recommendation was inferred from the evidence, this was indicated by the reference 'IDE' (inference derived from the evidence). The draft guidance, including the recommendations, was released for consultation in April 2008. At its meeting in June 2008, PHIAC considered comments from stakeholders and the results from fieldwork and amended the guidance. The guidance was signed off by the NICE Guidance Executive in July 2008. Appendix C: The evidence This appendix lists evidence statements provided by 2 reviews and links them to the relevant recommendations (see appendix B
